Health Care & Life Sciences » Pharmaceuticals | Sinovac Biotech Ltd.

Sinovac Biotech Ltd. | Mutual Funds

Mutual Funds that own Sinovac Biotech Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
132,153
0.22%
132,153
0.21%
06/30/2017
SPDR S&P Emerging Markets Small Cap ETF
71,350
0.12%
0
0.11%
09/06/2018
68,292
0.12%
3,647
1.65%
07/31/2018
SPDR S&P Emerging Markets ETF
34,748
0.06%
0
0.02%
09/06/2018
Fidelity Nasdaq Composite Index
27,717
0.05%
0
0%
07/31/2018
SPDR Russell 2000 Low Volatility ETF
24,723
0.04%
0
0.09%
09/06/2018
19,479
0.03%
0
0.19%
09/05/2018
SG Actions Monde Techno
8,100
0.01%
0
0.06%
01/31/2018
GLG Investments VI Plc - European Equity Alternative
3,931
0.01%
3,931
0%
06/30/2017
AST Goldman Sachs Multi Asset Portfolio
3,000
0.01%
0
0%
04/30/2018

About Sinovac Biotech

View Profile
Address
No. 15 Zhi Tong Road
Beijing Beijing 102200
China
Employees -
Website http://www.sinovacbio.com
Updated 07/08/2019
Sinovac Biotech Ltd. is a holding and biopharmaceutical company, which engages in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease. It operates through the Mainland China and Hong Kong geographical segments. Its product pipelines include Healive, Bilive, Anflu, PANFLU.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.